BIOAGE Labs Inc (BIOA)
22.14
+2.69%
BIOAGE Labs Inc (BIOA) is currently trading at $22.14. This represents a gain of 2.69% from the previous session. With a market capitalization of $0.93B, BIOA is a key component of the Real Estate sector. Investors looking to trade BIOA should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Claim Your $300 Cash Bonus →
T&Cs Apply. Trade BIOA commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, BIOAGE Labs Inc (BIOA) shows a bullish trend. Analysts are watching the 23.00 level closely.
Fundamentals
Mkt Cap0.93B
P/E Ratio0.0000
Volume476,459
60-Day Technical Chart
Advanced Charting
Need more indicators for BIOA? Use the world's #1 platform.
Open BIOA on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $22
| Metric |
BIOA +2.69% |
BMNR +10.60% |
HL -1.38% |
NCLH -0.63% |
|---|---|---|---|---|
| Price | $22.14 | $21.50 | $23.31 | $23.81 |
| Mkt Cap | $0.93B | $9.78B | $15.63B | $10.84B |
| - | View → | View → | View → |
Latest Headlines
Gossamer Bio stock tumbles 80% on trial miss
Investing.com • Feb 23, 2026
Gossamer Bio Stock Plummeted 82% Today — What’s Behind The Crash?
Stocktwits • Feb 23, 2026
Gossamer Bio stock tumbles again premarket as Phase 3 PAH miss rewrites the story
TechStock² • Feb 24, 2026
Upstream Bio’s stock drops 47% on verekitug Phase II asthma data
Clinical Trials Arena • Feb 12, 2026
Recent uptick might appease BioAge Labs, Inc. (NASDAQ:BIOA) institutional owners after losing 55% over the past year
Yahoo Finance • Nov 23, 2025
● Gemini Agentic AI Analyst Insight for BIOA
Market Education
- Trump’s New Tariffs Could Push Up Kitchen Renovation Costs Sep 26, 2025
- Canada Pension Plan - Top Stocks Nov 20, 2023
- Stocks with Cash and Low Debt Dec 10, 2023
External Research